SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is actively discussed following recent announcements of a $100 million public stock offering alongside a separate $100 million non-dilutive royalty financing deal, generating a split community reaction between concerns over dilution and recognition of strategic backing from a specialized biotech investor. Further interest surrounds the company's upcoming data presentation on its glioblastoma program at a key industry summit, with investors also awaiting anticipated updates for its broader oncology pipeline.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending on the heels of robust 2025 revenue, a significant patent extension for its key drugs until 2042, and the launch of a Phase 3 trial for IBSRELA in Chronic Idiopathic Constipation. The community is actively discussing these catalysts alongside heightened speculation regarding a potential acquisition and multiple analyst price target increases, despite some frustration over perceived stock manipulation.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending on excitement over its Galleri multi-cancer early detection test, with impressive PATHFINDER 2 study results and advancing FDA submission, boosted by strategic investments from Samsung and a new partnership with Hims & Hers to expand market access. The community is actively discussing the stock's significant long-term potential fueled by upcoming regulatory approvals and legislative support for Medicare coverage.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending due to its Q4 earnings report, which highlighted robust revenue growth, especially in the US, but also a net loss driven by increased credit loss provisions; this has sparked a heated community debate over whether the stock's substantial decline is an overreaction or signals fundamental issues within the buy now, pay later sector.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean Ltd. is trending following its transformative all-stock merger with Valaris, creating a global offshore drilling powerhouse with an expanded backlog and enhanced pricing power. The community anticipates a strong earnings report and is actively discussing the potential for a short squeeze as the offshore sector experiences a multi-year resurgence.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont (NEM) is trending as it reports strong earnings that exceeded expectations, fueling community excitement over the company's perceived undervaluation amid record-high gold prices and the potential for a significant upside as precious metal miners catch up to the metal's performance. The conversation centers on its financial strength and the broader market's lag in fully pricing in the current gold rally.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

OKLO is trending amidst a battle between technical indicators suggesting a potential bottom and bullish options activity, against persistent skepticism over its pre-revenue status and recent insider selling. The community is focused on its long-term promise to power AI data centers, while closely watching for a definitive break above key resistance levels.

Akamai Technologies, Inc. engages in the provision of cloud services for delivering, optimizing, and securing content and business applications over the Internet. Its products include security, web performance, media delivery, and network operator. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamai Technologies is trending as investors weigh strong Q4 results and its strategic pivot into high-growth AI-powered edge computing and cybersecurity against a cautious Q1 outlook, fueling community debate on its long-term growth trajectory.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to widespread community anticipation of its BLA resubmission for its Duchenne muscular dystrophy treatment and speculation surrounding potential shifts in the FDA's regulatory environment. Investors are noting increased institutional interest and discussing the drug's strong efficacy, envisioning substantial future growth and a potential short squeeze for the rare disease biotech.

Live Nation Entertainment, Inc. operates as an entertainment company. The firm engages in producing, marketing, and selling live concerts for artists via its global concert pipe. It operates through the following segments: Concerts, Sponsorship and Advertising, and Ticketing. The Concerts segment is involved in the promotion of live music events in owned or operated venues and in rented third-party venues. The Sponsorship and Advertising segment manages the development of strategic sponsorship programs in addition to the sale of international, national, and local sponsorships and placement of advertising such as signage, promotional programs, rich media offerings, including advertising associated with live streaming and music-related content, and ads across its distribution network of venues, events, and websites. The Ticketing segment is involved in the management of the global ticketing operations, including providing ticketing software and services to clients, and consumers with a marketplace, both online and mobile, for tickets and event information. The Ticketing segment is an agency business that sells tickets for events on behalf of its clients and retains a portion of the service charge as its fee. The company was founded in 1996 and is headquartered in Beverly Hills, CA.

Live Nation Entertainment Inc

Live Nation's latest earnings report, showing strong revenue but an EPS miss, is fueling debate as the company faces a significant DOJ antitrust lawsuit seeking to break up its alleged monopoly and a massive Ticketmaster data breach; community sentiment is split between bullish long-term growth expectations for live events and bearish concerns over legal and reputational fallout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exzeo Group (NYSE:XZO) Stock Price Down 13.1% - Here's Why

Exzeo Group (NYSE:XZO) Shares Down 13.1% - What's Next...

Exzeo Group, Inc. (NYSE:XZO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Exzeo Group, Inc. (NYSE:XZO - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five analysts that are presently covering the stock, MarketBeat reports. Two analysts...

Exzeo Group (NYSE:XZO) Trading Up 1.7% - Time to Buy?

Exzeo Group (NYSE:XZO) Stock Price Up 1.7% - Here's Why...

Exzeo Group (NYSE:XZO) Stock Price Down 4.6% - Here's What Happened

Exzeo Group (NYSE:XZO) Stock Price Down 4.6% - Should You Sell...

Exzeo Group (NYSE:XZO) Reaches New 1-Year High - What's Next?

Exzeo Group (NYSE:XZO) Hits New 1-Year High - Here's What Happened...

Exzeo Group (NYSE:XZO) Shares Up 3.5% - Still a Buy?

Exzeo Group (NYSE:XZO) Trading 3.5% Higher - Should You Buy...

Exzeo Group (NYSE:XZO) Shares Gap Up on Insider Buying Activity

Exzeo Group (NYSE:XZO) Shares Gap Up on Insider Buying Activity...

Brook Armstrong Baker Acquires 10,020 Shares of Exzeo Group (NYSE:XZO) Stock

Exzeo Group, Inc. (NYSE:XZO - Get Free Report) General Counsel Brook Armstrong Baker bought 10,020 shares of the company's stock in a transaction on Thursday, December 18th. The stock was bought at...

Insider Buying: Exzeo Group (NYSE:XZO) CFO Buys 10,020 Shares of Stock

Exzeo Group, Inc. (NYSE:XZO - Get Free Report) CFO Suela Bulku acquired 10,020 shares of the firm's stock in a transaction dated Thursday, December 18th. The stock was bought at an average price of...

Kevin Andrew Mitchell Buys 12,510 Shares of Exzeo Group (NYSE:XZO) Stock

Exzeo Group, Inc. (NYSE:XZO - Get Free Report) President Kevin Andrew Mitchell bought 12,510 shares of Exzeo Group stock in a transaction dated Thursday, December 18th. The shares were bought at an...

Exzeo Group, Inc. operates as a provider of turnkey insurance technology and operations solutions to insurance carriers and their agents based on a proprietary platform of purpose-built software and data analytics applications that are specifically designed for the property and casualty, or P&C, insurance ecosystem. Its Insurance-as-a-Service (IaaS) platform includes nine highly configurable software and data analytics applications that are purpose-built to serve insurance companies and other customers in the insurance value chain. The company was founded by Paresh Patel in 2012 and is headquartered in Tampa, FL.

Current Price	$16.28
Prev Close	$16.20
Open	$16.02
Dividend Yield	N/A
50-Day Moving Average	$20.16
Beta	0.32
Avg. Volume	120,987.95
PE Ratio	N/A

52-Week High	$24.60
52-Week Low	$12.92
Market Capitalization	$1.47B
EPS (Annual)	$0.374
Price to Book	18.75
Revenue Per Employee	N/A

XZO
Exzeo Group Ord Shs

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest XZO News

XZOExzeo Group Ord Shs